Season 7 · Episode 20
S7 Ep20: Gradishar Stresses the Importance of Accurately Defining Breast Cancer Subtypes
OncLive® On Air · OncLive® On Air
August 4, 202216m 28s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Gradishar emphasizes the importance of defining metastatic breast cancer subtypes, the implications of molecular testing and genetics on treatment decisions, and the need for honest and comprehensive patient-provider communication about therapeutic options and clinical trial opportunities throughout the course of disease.